The genotoxicity of fluoride in vivo in seven patients with osteoporosis was cytogenetically investigated. The patients were treated with fluoride- containing formulations (disodium monofluorophosphate and sodium fluoride) for a period of 15 months up to 49 months. Fluoride intake ranged from 22.6- 33.9 mg F-/day and serum fluoride concentrations were between 0.1 mg F-/l and 0.2 mg F-/l. Peripheral blood lymphocytes of these patients were cultured in vitro and examined for chromosomal aberrations, micronuclei in cytokinesis-blocked binucleated lymphocytes as well as cell cycle progression. When a comparison was made between patients' group and a matched control group, it was found that fluoride at the tested concentrations had no detectable genotoxic potential in human lymphocytes in vivo.
CITATION STYLE
Van Asten, P., Darroudi, F., Natarajan, A. T., Terpstra, I. J., & Duursma, S. A. (1998). Cytogenetic effects on lymphocytes in osteoporotic patients on long- term fluoride therapy. Pharmacy World and Science, 20(5), 214–218. https://doi.org/10.1023/A:1008672220053
Mendeley helps you to discover research relevant for your work.